Literature DB >> 23454615

Functional aspects of PARylation in induced and programmed DNA repair processes: preserving genome integrity and modulating physiological events.

Isabelle Robert1, Olga Karicheva, Bernardo Reina San Martin, Valérie Schreiber, Françoise Dantzer.   

Abstract

To cope with the devastating insults constantly inflicted to their genome by intrinsic and extrinsic DNA damaging sources, cells have evolved a sophisticated network of interconnected DNA caretaking mechanisms that will detect, signal and repair the lesions. Among the underlying molecular mechanisms that regulate these events, PARylation catalyzed by Poly(ADP-ribose) polymerases (PARPs), appears as one of the earliest post-translational modification at the site of the lesion that is known to elicit recruitment and regulation of many DNA damage response proteins. In this review we discuss how the complex PAR molecule operates in stress-induced DNA damage signaling and genome maintenance but also in various physiological settings initiated by developmentally programmed DNA breakage. To illustrate the latter, particular emphasis will be placed on the emerging contribution of PARPs to B cell receptor assembly and diversification.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Keywords:  B cell receptor assembly and diversification; DNA repair; Developmentally programmed DNA damage; Genome integrity; Poly(ADP-ribose) polymerases; Stress-induced DNA damage

Mesh:

Substances:

Year:  2013        PMID: 23454615     DOI: 10.1016/j.mam.2013.02.001

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  12 in total

1.  PARP-2 depletion results in lower radiation cell survival but cell line-specific differences in poly(ADP-ribose) levels.

Authors:  Mohammed-Tayyib Boudra; Celeste Bolin; Sara Chiker; Alexis Fouquin; Tomasz Zaremba; Laurence Vaslin; Denis Biard; Fabrice P Cordelières; Frédérique Mégnin-Chanet; Vincent Favaudon; Marie Fernet; Vincent Pennaneach; Janet Hall
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

2.  Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells.

Authors:  Lisa Rank; Sebastian Veith; Eva C Gwosch; Janine Demgenski; Magdalena Ganz; Marjolijn C Jongmans; Christopher Vogel; Arthur Fischbach; Stefanie Buerger; Jan M F Fischer; Tabea Zubel; Anna Stier; Christina Renner; Michael Schmalz; Sascha Beneke; Marcus Groettrup; Roland P Kuiper; Alexander Bürkle; Elisa Ferrando-May; Aswin Mangerich
Journal:  Nucleic Acids Res       Date:  2016-09-29       Impact factor: 16.971

Review 3.  Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments.

Authors:  Hongwei Liao; Fang Ji; Thomas Helleday; Songmin Ying
Journal:  EMBO Rep       Date:  2018-08-13       Impact factor: 8.807

4.  Parp3 negatively regulates immunoglobulin class switch recombination.

Authors:  Isabelle Robert; Léa Gaudot; Mélanie Rogier; Vincent Heyer; Aurélia Noll; Françoise Dantzer; Bernardo Reina-San-Martin
Journal:  PLoS Genet       Date:  2015-05-22       Impact factor: 5.917

5.  Poly(ADP-ribose)-mediated interplay of XPA and PARP1 leads to reciprocal regulation of protein function.

Authors:  Jan M F Fischer; Oliver Popp; Daniel Gebhard; Sebastian Veith; Arthur Fischbach; Sascha Beneke; Alfred Leitenstorfer; Jörg Bergemann; Martin Scheffner; Elisa Ferrando-May; Aswin Mangerich; Alexander Bürkle
Journal:  FEBS J       Date:  2014-07-21       Impact factor: 5.542

6.  Characterization of the interactions of PARP-1 with UV-damaged DNA in vivo and in vitro.

Authors:  Nupur K Purohit; Mihaela Robu; Rashmi G Shah; Nicholas E Geacintov; Girish M Shah
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

7.  LncRNA-SLC6A9-5:2: A potent sensitizer in 131I-resistant papillary thyroid carcinoma with PARP-1 induction.

Authors:  Cheng Xiang; Mao-Lin Zhang; Qun-Zi Zhao; Qiu-Ping Xie; Hai-Chao Yan; Xing Yu; Ping Wang; Yong Wang
Journal:  Oncotarget       Date:  2017-04-04

Review 8.  PARP inhibitors in gastric cancer: beacon of hope.

Authors:  Yali Wang; Kun Zheng; Yongbiao Huang; Hua Xiong; Jinfang Su; Rui Chen; Yanmei Zou
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24

9.  PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways.

Authors:  Carole Beck; Christian Boehler; Josée Guirouilh Barbat; Marie-Elise Bonnet; Giuditta Illuzzi; Philippe Ronde; Laurent R Gauthier; Najat Magroun; Anbazhagan Rajendran; Bernard S Lopez; Ralph Scully; François D Boussin; Valérie Schreiber; Françoise Dantzer
Journal:  Nucleic Acids Res       Date:  2014-03-05       Impact factor: 16.971

10.  PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency.

Authors:  Aurélia Noll; Giuditta Illuzzi; Jean-Christophe Amé; Françoise Dantzer; Valérie Schreiber
Journal:  Cancer Cell Int       Date:  2016-07-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.